Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Eli Lilly
Description:
An American pharmaceutical company that develops and markets medicines, including treatments for diabetes and other diseases.
Related topic:
Pharmaceutical Economics and Policy (17%)
OpenAlex ID:
keywords/eli-lilly
Collaborating to create: The Internet as a platform for customer engagement in product innovation
2005
·
Mohanbir Sawhney
, Gianmario Verona
, et al.
·
Journal of Interactive Marketing
·
1,802
Insulin: Discovery and Controversy
2002
·
Louis Rosenfeld
·
Clinical Chemistry
·
400
A Trail of Research from Lipoic Acid to α-Keto Acid Dehydrogenase Complexes
2001
·
Lester J. Reed
·
Journal of Biological Chemistry
·
302
Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli Lilly
2006
·
Peter Q. Eichacker
, Charles Natanson
, et al.
·
New England Journal of Medicine
·
215
Alzheimer's failure raises questions about disease-modifying strategies
2010
·
Andy Extance
·
Nature Reviews Drug Discovery
·
176
Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
2010
·
Barry I. Eisenstein
, Frederick B. Oleson, Jr.
, et al.
·
Clinical Infectious Diseases
·
165
Learning to collaborate through collaboration: How allying with expert firms influences collaborative innovation within novice firms
2015
·
Michael Howard
, H. Kevin Steensma
, et al.
·
Strategic Management Journal
·
161
Exploiting a Research Underclass in Phase 1 Clinical Trials
2008
·
Carl Elliott
, Roberto Abadie
·
New England Journal of Medicine
·
143
Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications
2014
·
E. Maund
, B. Tendal
, et al.
·
BMJ
·
92
PDF
A more rational approach to new-product development.
2008
·
Eric Bonabeau
, Neil Bodick
, et al.
·
PubMed
·
83
Location Trends of Large Company Headquarters during the 1990s.(statistical Data Included)
2002
·
Thomas Klier
, William A. Testa
·
64
Open Innovation for Phenotypic Drug Discovery: The PD2 Assay Panel
2011
·
Jonathan A. Lee
, Shaoyou Chu
, et al.
·
SLAS DISCOVERY
·
62
Leadership as the Enabler of Strategizing and Organizing
2006
·
Ian D. Colville
, Anthony J. Murphy
·
Long Range Planning
·
62
Making the Unit of Insulin: Standards, Clinical Work, and Industry, 1920-1925
2002
·
Christiane Sinding
·
Bulletin of the history of medicine
·
60
Prevalence and Outcomes of Pharmaceutical Industry—Sponsored Clinical Trials Involving Clozapine, Risperidone, or Olanzapine
2004
·
Ric M Procyshyn
, Anthony Chau
, et al.
·
The Canadian Journal of Psychiatry
·
57
PDF
Drotrecogin alfa (activated) ... a sad final fizzle to a roller-coaster party
2012
·
Derek C Angus
·
Critical Care
·
56
PDF
From ugly fish to conquer death: J J R Macleod's fish insulin research, 1922–24
2002
·
James R Wright
·
The Lancet
·
51
Poisoning the Spindle: Serendipity and Discovery of the Anti-Tumor Properties of the Vinca Alkaloids
2000
·
Jacalyn Duffin
·
Canadian Journal of Health History
·
51
PDF
The Discovery of Insulin: the Work of Frederick Banting and Charles Best
2002
·
Robert D. Simoni
, Robert L. Hill
, et al.
·
Journal of Biological Chemistry
·
49
The Future of Basal Insulin Supplementation
2011
·
Airin C.R. Simon
, J. Hans DeVries
·
Diabetes Technology & Therapeutics
·
47
The promotion of olanzapine in primary care: An examination of internal industry documents
2009
·
Glen I. Spielmans
·
Social Science & Medicine
·
44
Duloxetine Eli Lilly & Co.
2000
·
N Pitsikas
·
PubMed
·
44
FDA to Require Diabetes Warning On Antipsychotics
2003
·
Jim Rosack
·
Psychiatric News
·
41
Recombinant human parathyroid hormone
2002
·
J. Reeve
·
BMJ
·
41
What Industrial Chemists Want—Are Academics Giving It to Them?
2018
·
Colin Diner
, Michael G. Organ
·
Organometallics
·
37
Show more works
View as search
Works count:
1,004
Citation count:
5,654
Year
Topic
Type